Most Americans were told the 21st Century Cures Act was about speeding up medical innovation and helping address the opioid crisis. What almost no one was told is that Section 3024 of the Act allows Institutional Review Boards (IRBs) to waive informed consent under a “minimal risk” classification, even as technologies become more advanced, invasive, and experimental. In this clip, Jesse explains... How the Act was passed in 2016 under the Obama administration. How Section 3024 was not part of th

21st Century Cures Act: Patient Data Access and Information Blocking | Michele Mitchell posted on the topic | LinkedIn